Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00520624
Other study ID # PC-EIL-07-ELITE
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date January 2013
Est. completion date January 2020

Study information

Verified date January 2021
Source Bispebjerg Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Treatment of exercise-induced laryngomalacia (an obstruction of larynx during physical activity) in elite athletes using two different treatments. The study is randomized with control groups.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 2020
Est. primary completion date January 2020
Accepts healthy volunteers No
Gender All
Age group 12 Years and older
Eligibility Inclusion Criteria: - Laryngoscopically verified EIL, - Elite athlete for a minimum of 1 year and continuing for a minimum 6 months after start of treatment Exclusion Criteria: - Has to be able to run on treadmill

Study Design


Related Conditions & MeSH terms


Intervention

Device:
inspiratory muscle strength training

Procedure:
Surgery


Locations

Country Name City State
Denmark Bispebjerg Hospital, Lungemedicinsk Forskningsenhed Copenhagen

Sponsors (2)

Lead Sponsor Collaborator
Bispebjerg Hospital Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark,